Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

FX Contra

K-Number: K222518 · 2022-11-17

Decision Date2022-11-17
Product CodeEGS
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

FX Contra is a medical device manufactured by Nakanishi, Inc.. It received FDA 510(k) clearance on 2022-11-17 under approval number K222518. The device is classified under product code EGS. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the FX Contra?

FX Contra is a medical device that received FDA 510(k) clearance on 2022-11-17. It is manufactured by Nakanishi, Inc.. The 510(k) number is K222518.

When was FX Contra approved by the FDA?

FX Contra received FDA 510(k) clearance on 2022-11-17, under approval number K222518.

What company makes FX Contra?

FX Contra is manufactured by Nakanishi, Inc..

What is the FDA product code for FX Contra?

The FDA product code for FX Contra is EGS.

Other Devices by Nakanishi, Inc.

View all 21 devices →

Related Devices (Code: EGS)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.